Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK

Abstract

The direct medical costs for the NHS associated with detection and management of CC, cervical dysplasia and treatment of GW in the UK are substantial. These medical costs are invaluable for future cost-effectiveness analyses of a quadrivalent HPV vaccine programme.